By Josh White
Date: Wednesday 17 Sep 2025
(Sharecast News) - Hikma Pharmaceuticals and Kier Group both reported director share dealings on Wednesday.
Holding(s) in Company | 17-Sep-2025 | 13:13 | RNS |
Director/PDMR Shareholding | 17-Sep-2025 | 09:15 | RNS |
Holding(s) in Company | 16-Sep-2025 | 13:01 | RNS |
Holding(s) in Company | 16-Sep-2025 | 13:00 | RNS |
FY25 Results | 16-Sep-2025 | 07:00 | RNS |
Questor:Kier Group | 01-Dec-2011 | Telegraph |
Investment Column:Kier | 16-Sep-2011 | The Independent |
Questor:Kier Group | 24-Jun-2011 | Telegraph |
Questor : Kier Group | 25-Nov-2010 | Telegraph |
Investment Column:Kier | 23-Nov-2010 | The Independent |
No recent information was found.
Currency | UK Pounds |
Share Price | 205.50p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 214.50 |
52 Week Low | 115.20 |
Volume | 1,437,604 |
Shares Issued | 446.47m |
Market Cap | £917.49m |
Beta | 0.01 |
RiskGrade | 260 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 5 |
Buy | 1 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 7 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 30-Oct-25 | 24-Apr-25 |
Paid | 03-Dec-25 | 02-Jun-25 |
Amount | 5.20p | 2.00p |
Time | Volume / Share Price |
16:02 | 44 @ 207.00p |
16:02 | 44 @ 207.00p |
16:42 | 70 @ 205.00p |
16:38 | 2,985 @ 205.50p |
16:38 | 5,376 @ 205.50p |
CEO | Andrew Davies |
CFO | Simon Kesterton |
Chair | Matthew Lester |
You are here: research